Suppr超能文献

[泌尿生殖系统肿瘤的分子病理学:2019年国际泌尿病理学会(ISUP)共识会议的建议]

[Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference].

作者信息

Hommerding Oliver, Allory Yves, Argani Pedram, Bismar Tarek A, Bubendorf Lukas, Canete-Portillo Sofía, Chaux Alcides, Chen Ying-Bei, Cheng Liang, Cubilla Antonio L, Egevad Lars, Gill Anthony J, Grignon David J, Hartmann Arndt, Hes Ondrej, Idrees Muhammad T, Kao Chia-Sui, Knowles Margaret A, Looijenga Leendert H J, Lotan Tamara L, Pritchard Colin C, Rubin Mark A, Tomlins Scott A, Van der Kwast Theodorus H, Velazquez Elsa F, Warrick Joshua I, Williamson Sean R, Kristiansen Glen

机构信息

Institut für Pathologie, Universitätsklinikum Bonn, Venusberg-Campus 1, Gebäude 62, 53127, Bonn, Deutschland.

Department of Pathology, Institut Curie, Saint-Cloud, Frankreich.

出版信息

Pathologe. 2021 May;42(3):310-318. doi: 10.1007/s00292-020-00888-4. Epub 2021 Jan 4.

Abstract

Comprehensive understanding of molecular principles in cancer and the diversification of oncological therapy promise individual therapeutic concepts, which have not yet found their way into urogenital cancer therapy. In March 2019 the International Society of Urogenital Pathology (ISUP) therefore held a consensus conference on recommendations for molecular diagnostics of genitourinary tumors, which were published in five separate manuscripts and are summarized in this article.In preparation for the conference, a comprehensive survey of current practices for molecular testing of urogenital tumors was carried out by members of the ISUP. At the conference, the results and the corresponding background information were presented by five working groups and recommendations for action for diagnostics were developed. An agreement between 66% of the conference participants was defined as consensus.

摘要

全面理解癌症的分子原理以及肿瘤治疗方法的多样化有望实现个性化治疗理念,但这些理念尚未应用于泌尿生殖系统癌症的治疗。因此,2019年3月,国际泌尿生殖病理学会(ISUP)召开了一次关于泌尿生殖系统肿瘤分子诊断建议的共识会议,相关内容发表在五篇独立的手稿中,并在本文中进行了总结。在会议筹备过程中,ISUP成员对泌尿生殖系统肿瘤分子检测的当前实践进行了全面调查。会议上,五个工作组介绍了调查结果及相应的背景信息,并制定了诊断行动建议。66%的与会者达成的一致意见被定义为共识。

相似文献

本文引用的文献

7
[Predictive biomarkers in bladder cancer].[膀胱癌中的预测性生物标志物]
Pathologe. 2019 Dec;40(Suppl 3):331-338. doi: 10.1007/s00292-019-00688-5.
9
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.肌肉浸润性膀胱癌的共识分子分类。
Eur Urol. 2020 Apr;77(4):420-433. doi: 10.1016/j.eururo.2019.09.006. Epub 2019 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验